@article{article, title  = {{Proposed denosumab biosimilar SB16 vs reference denosumab in postmenopausal osteoporosis: phase 3 results up to month 12}},

 publisher = {{The Endocrine Society}},

 url = {{https://eprints.whiterose.ac.uk/id/eprint/218247 }},

 year = {{2024}},

 month = {{9}},

 author = {{Langdahl B and Chung Y-S and Plebanski R and Czerwinski E and Dokoupilova E and Supronik J and Rosa J and Mydlak A and Rowińska-Osuch A and Baek K-H and Urboniene A et al}},

 doi = {{10.1210/clinem/dgae611}},

 volume = {{110}},

 journal = {{The Journal of Clinical Endocrinology & Metabolism}},

 issue = {{6}},

 note = {{Accessed on 2025/12/17}}}